Although the initial finding of the protumorigenic properties of OGR1 was made using in vitro human CRC cell lines driven by clinically-relevant mutant proteins, we were able to demonstrate these pathologies translated to an in vivo mouse model of tumor growth. Here, GPR68 is linked to colorectal carcinoma.